胰腺β细胞脱差作为糖尿病β细胞衰竭的机制
Chutima Talchai1, Shouhong Xuan, Hua V Lin
1Department of Medicine, Columbia University, New York, NY 10032, USA.
Cell
|September 18, 2012
概括
在胰腺β细胞中缺少叉头盒蛋白1 (FoxO1) 会导致高血糖症,因为它会导致细胞分化,而不是细胞死亡. 这一发现表明恢复β细胞分化可能治疗糖尿病.
科学领域:
- 内分泌学 在内分泌学.
- 细胞生物学 细胞生物学
- 糖尿病研究 糖尿病研究
背景情况:
- 糖尿病的特征是胰腺β细胞衰竭,但潜在的机制 (减少细胞数量与功能) 仍在争论中.
- 叉头盒蛋白1 (FoxO1) 是一个关键的调节器,集成β细胞增殖和适应功能.
- 福克斯O1在β细胞质量和在压力期间的功能中的确切作用仍然不完全理解.
研究的目的:
- 调查β细胞增殖和功能在没有FoxO1.1的情况下对功能障碍的贡献.
- 为了阐明驱动β细胞在生理压力下减少质量的机制.
- 为了确定FoxO1缺乏β细胞衰竭是否反映了在其他糖尿病模型中观察到的途径.
主要方法:
- 使用了缺乏FoxO1的转基因小鼠,特别是在β细胞中.
- 通过多对和衰老诱导的生理压力.
- 采用血统追踪实验来追踪β细胞的命运.
- 分析了β细胞质量,功能和基因表达特征.
主要成果:
- 在β细胞中FoxO1的剥离导致高血糖症,并在压力后减少β细胞质量.
- 血统追踪显示β细胞脱差为前代类细胞 (表达神经新生素3,Oct4,Nanog,L-Myc),而不是亡.
- 缺乏FoxO1的β细胞的一个子集转化为α细胞,导致高葡萄糖血症.
- 这些脱差和转差事件在多个小鼠糖尿病模型中观察到.
结论:
- 糖尿病中的β细胞衰竭主要是由脱差而不是细胞死亡驱动的.
- 失去FoxO1促进β细胞脱差异化和转差异化成α细胞.
- 治疗β细胞功能障碍的治疗策略应侧重于恢复分化,而不仅仅是促进复制.
更多相关视频
07:44Surgical Injury to the Mouse Pancreas through Ligation of the Pancreatic Duct as a Model for Endocrine and Exocrine Reprogramming and Proliferation
Published on: August 7, 2015
16.0K
06:53Intramuscular Transplantation of Human Pluripotent Stem Cell-derived Pancreatic Endocrine Cells in Mice
Published on: April 10, 2026
93
相关概念视频
Insulin Secretory Vesicles
6.3K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.3K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.8K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.8K
Pathophysiology of Diabetes
3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Type I Diabetes I: Introduction
45
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45
Type I Diabetes II: Pathophysiology
75
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
